Gastrointestinal Molecular Diagnostics Market: By Test Type (Endoscope, Blood Test, and Other), By Technology (Polymer Chain Reaction, Next-Generation Sequencing, In Situ Hybridization (ISH), and Microarrays), By Disease Indication (Viruses, Bacteria, Parasite, and Others), By Application (Infectious Diseases, Gastrointestinal Cancers, and Personalized Medicine), By End-users (Hospital & Clinics, Research Institution, and Diagnostic Laboratories), Geography

Purchase Option

$ 4400
$ 6600
$ 8900

Gastrointestinal Molecular Diagnostics Market size was valued at USD 4.3 billion in 2023, and is poised to grow at a CAGR of 3.6% from 2024 to 2030. The gastrointestinal molecular diagnostics market is anticipated to witness significant growth in the coming years, driven by several factors, such as the rising prevalence of gastrointestinal diseases, technological advancement (next-generation sequencing and PCR), growing awareness of the benefits of molecular diagnostics, and additionally supportive government policies around the world are creating a fertile ground for the global gastrointestinal molecular diagnostics market to flourish. Which empowers doctors to pinpoint and characterize genetic mutations linked to gastrointestinal diseases with exceptional precision and sensitivity. This, coupled with the growing need for early diagnoses and personalized treatments, which driving the gastrointestinal molecular diagnostics market demand in the fight against gastrointestinal ailments.

Gastrointestinal Molecular Diagnostics Market Key Developments:
  • In June 2022, the SENTiFIT 800 analyzer, an automated system for Fecal Immunochemical tests, was launched by Sentinel Diagnostics.
  • In March 2022, the agreement between Hardy Diagnostic and Applied BioCode for the distribution of the MDx-3000 System for the diagnosis of gastrointestinal infections. 

Gastrointestinal Molecular Diagnostics Market Summary

Study Period

2024-2030

Base Year

2023

CAGR

3.6%

Largest Market

North America

Fastest Growing Market

Asia Pacific
Gastrointestinal Molecular Diagnostics Market Dynamics

The gastrointestinal molecular diagnostics market is expected to continue its growth trajectory in the coming years, driven by the increasing burden of gastrointestinal diseases according to the University of Gothenburg, in every ten adults in the world, four suffer from GIDs of varying severity, technological advancements in molecular biology techniques, such as next-generation sequencing (NGS) are leading to the development of more specific and sensitive diagnostic tests, and a growing emphasis on personalized medicine.  However, addressing challenges related to cost and regulatory hurdles will be crucial for sustained market expansion.

Gastrointestinal Molecular Diagnostics Market Segmentation

By Test Type
  • Endoscope
  • Blood Test
  • Others
By Technology
  • Polymer Chain Reaction
  • Next-Generation Sequencing
  • In Situ Hybridization (ISH)
  • Microarrays
By Disease Indication
  • Virus
    Norovirus
    Adenovirus
    Rotavirus
    Sapovirus
  • Bacteria
    Difficle
    Salmonella
    Shigella
  • Parasite
    Cryptosporidium
    Entamoeba histolytica
    Giardia Lamblia 
  • Others
By Application
  • Infectious Diseases
  • Gastrointestinal Cancers
  • Personalized Medicine
By End User
  • Hospital & Clinics
  • Research Institution
  • Diagnostic Laboratories

Frequently Asked Questions

The gastrointestinal molecular diagnostics market is valued at USD 4.3 billion in 2023, and is poised to grow at a (CAGR) of 3.6% from 2024 to 2030.

F. Hoffmann-La Roche AG, Abbott Laboratories, Danaher Corporation (Cepheid), Hologic, bioMérieux SA, Illumina, Inc., QIAGEN, BD, Bio-Rad Laboratories, Inc., Agilent Technologies, Inc., Illumina, Inc.., Grifols, S.A., Siemens Healthineers AG, and Sysmex Corporation.

Asia-Pacific is the fastest growing and North America is the dominant market in Gastrointestinal molecular diagnostics

Key Features of the Reports

  • The gastrointestinal molecular diagnostics market report provides granular level information about the market size, regional market share, historic market (2019-2023), and forecast (2024-2030)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and key strategies.
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market.
  • The report tracks recent innovations, key developments, and start-up details that are actively working in the market.
  • The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenarios.
1.Executive Summary
2.Global Gastrointestinal Molecular Diagnostics Market Introduction 
2.1.Global Gastrointestinal Molecular Diagnostics Market  - Taxonomy
2.2.Global Gastrointestinal Molecular Diagnostics Market  - Definitions
2.2.1.Test Type
2.2.2.Technology
2.2.3.Disease Indication
2.2.4.Region
3.Global Gastrointestinal Molecular Diagnostics Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Product Landscape
3.6. New Product Launches
3.7. Impact of COVID 19 on Market
4.Global Gastrointestinal Molecular Diagnostics Market Analysis, 2019 - 2023 and Forecast 2024 - 2030
4.1.  Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
4.2.  Year-Over-Year (Y-o-Y) Growth Analysis (%) 
4.3.  Market Opportunity Analysis 
5.Global Gastrointestinal Molecular Diagnostics Market  By Test Type, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
5.1. Endoscope
5.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.1.3. Market Opportunity Analysis 
5.2. Blood Test
5.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.2.3. Market Opportunity Analysis 
5.3. Others
5.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.3.3. Market Opportunity Analysis 
6.Global Gastrointestinal Molecular Diagnostics Market  By Technology, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
6.1. Polymer Chain Reaction
6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.1.3. Market Opportunity Analysis 
6.2. Next-Generation Sequencing
6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.2.3. Market Opportunity Analysis 
6.3. In Situ Hybridization (ISH)
6.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.3.3. Market Opportunity Analysis 
6.4. Microarrays
6.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.4.3. Market Opportunity Analysis 
7.Global Gastrointestinal Molecular Diagnostics Market  By Disease Indication, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
7.1. Virus
7.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.1.3. Market Opportunity Analysis 
7.2. Bacteria
7.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.2.3. Market Opportunity Analysis 
7.3. Parasite
7.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.3.3. Market Opportunity Analysis 
7.4. Others
7.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.4.3. Market Opportunity Analysis 
8.Global Gastrointestinal Molecular Diagnostics Market  By Region, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
8.1. North America
8.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.1.3. Market Opportunity Analysis 
8.2. Europe
8.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.2.3. Market Opportunity Analysis 
8.3. Asia Pacific (APAC)
8.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.3.3. Market Opportunity Analysis 
8.4. Middle East and Africa (MEA)
8.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.4.3. Market Opportunity Analysis 
8.5. Latin America
8.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.5.3. Market Opportunity Analysis 
9.North America Gastrointestinal Molecular Diagnostics Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
9.1. Test Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.1.1.Endoscope
9.1.2.Blood Test
9.1.3.Others
9.2.  Technology Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.2.1.Polymer Chain Reaction
9.2.2.Next-Generation Sequencing
9.2.3.In Situ Hybridization (ISH)
9.2.4.Microarrays
9.3.  Disease Indication Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.3.1.Virus
9.3.2.Bacteria
9.3.3.Parasite
9.3.4.Others
9.4.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.4.1.United States of America (USA)
9.4.2.Canada
10.Europe Gastrointestinal Molecular Diagnostics Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
10.1. Test Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.1.1.Endoscope
10.1.2.Blood Test
10.1.3.Others
10.2.  Technology Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.2.1.Polymer Chain Reaction
10.2.2.Next-Generation Sequencing
10.2.3.In Situ Hybridization (ISH)
10.2.4.Microarrays
10.3.  Disease Indication Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.3.1.Virus
10.3.2.Bacteria
10.3.3.Parasite
10.3.4.Others
10.4.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.4.1.Germany
10.4.2.France
10.4.3.Italy
10.4.4.United Kingdom (UK)
10.4.5.Spain
11.Asia Pacific (APAC) Gastrointestinal Molecular Diagnostics Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
11.1. Test Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.1.1.Endoscope
11.1.2.Blood Test
11.1.3.Others
11.2.  Technology Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.2.1.Polymer Chain Reaction
11.2.2.Next-Generation Sequencing
11.2.3.In Situ Hybridization (ISH)
11.2.4.Microarrays
11.3.  Disease Indication Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.3.1.Virus
11.3.2.Bacteria
11.3.3.Parasite
11.3.4.Others
11.4.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.4.1.China
11.4.2.India
11.4.3.Australia and New Zealand (ANZ)
11.4.4.Japan
11.4.5.Rest of APAC
12.Middle East and Africa (MEA) Gastrointestinal Molecular Diagnostics Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
12.1. Test Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.1.1.Endoscope
12.1.2.Blood Test
12.1.3.Others
12.2.  Technology Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.2.1.Polymer Chain Reaction
12.2.2.Next-Generation Sequencing
12.2.3.In Situ Hybridization (ISH)
12.2.4.Microarrays
12.3.  Disease Indication Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.3.1.Virus
12.3.2.Bacteria
12.3.3.Parasite
12.3.4.Others
12.4.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.4.1.GCC Countries
12.4.2.South Africa
12.4.3.Rest of MEA
13.Latin America Gastrointestinal Molecular Diagnostics Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
13.1. Test Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.1.1.Endoscope
13.1.2.Blood Test
13.1.3.Others
13.2.  Technology Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.2.1.Polymer Chain Reaction
13.2.2.Next-Generation Sequencing
13.2.3.In Situ Hybridization (ISH)
13.2.4.Microarrays
13.3.  Disease Indication Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.3.1.Virus
13.3.2.Bacteria
13.3.3.Parasite
13.3.4.Others
13.4.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.4.1.Brazil
13.4.2.Mexico
13.4.3.Rest of LA
14. Competition Landscape
14.1.  Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) 
14.2.1.Hoffmann-La Roche AG
14.2.2.Abbott Laboratories
14.2.3.Danaher Corporation (Cepheid)
14.2.4.Hologic, Inc.
14.2.5.bioMérieux SA
14.2.6.Illumina, Inc.
14.2.7.QIAGEN
14.2.8.BD
14.2.9.Bio-Rad Laboratories, Inc.
14.2.10.Agilent Technologies, Inc.
14.2.11.Illumina, Inc.
14.2.12.Grifols, S.A.
14.2.13.Siemens Healthineers AG
14.2.14.Sysmex Corporation
15. Research Methodology 
16. Appendix and Abbreviations 
  • Hoffmann-La Roche AG
  • Abbott Laboratories
  • Danaher Corporation (Cepheid)
  • Hologic, Inc.
  • bioMérieux SA
  • Illumina, Inc.
  • QIAGEN
  • BD
  • Bio-Rad Laboratories, Inc.
  • Agilent Technologies, Inc.
  • Illumina, Inc.
  • Grifols, S.A.
  • Siemens Healthineers AG
  • Sysmex Corporation

Adjacent Markets